Cozad Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,148
Closed -$224K 391
2023
Q2
$224K Buy
4,148
+70
+2% +$3.77K 0.03% 348
2023
Q1
$222K Buy
+4,078
New +$198K 0.03% 342
2022
Q3
Sell
-5,252
Closed -$263K 367
2022
Q2
$263K Hold
5,252
0.04% 300
2022
Q1
$270K Sell
5,252
-375
-7% -$19.4K 0.04% 313
2021
Q4
$282K Hold
5,627
0.04% 288
2021
Q3
$271K Hold
5,627
0.04% 287
2021
Q2
$296K Sell
5,627
-47
-0.8% -$2.45K 0.05% 277
2021
Q1
$281K Buy
5,674
+340
+6% +$16.3K 0.05% 288
2020
Q4
$259K Sell
5,334
-146
-3% -$7.2K 0.05% 277
2020
Q3
$275K Sell
5,480
-257
-4% -$13.2K 0.05% 264
2020
Q2
$293K Buy
5,737
+438
+8% +$21.3K 0.06% 251
2020
Q1
$232K Sell
5,299
-364
-6% -$17.4K 0.08% 188
2019
Q4
$284K Buy
5,663
+195
+4% +$9.13K 0.08% 202
2019
Q3
$253K Sell
5,468
-55
-1% -$2.37K 0.07% 211
2019
Q2
$239K Sell
5,523
-290
-5% -$12.3K 0.07% 215
2019
Q1
$257K Hold
5,813
0.08% 206
2018
Q4
$252K Sell
5,813
-531
-8% -$23.4K 0.09% 197
2018
Q3
$283K Sell
6,344
-240
-4% -$10.3K 0.08% 192
2018
Q2
$263K Buy
+6,584
New +$259K 0.08% 195

Other funds holding SNY

Cozad Asset Management's SNY Position: Q3 2023 in Review

Cozad Asset Management sold out of Sanofi (SNY) in Q3 2023, closing a stake of 4,148 shares — an estimated $224K sold.

Cozad Asset Management first reported a position in SNY in Q2 2018 and held it in 19 quarters. The position peaked at $296K in Q2 2021. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • Cozad Asset Management reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • Cozad Asset Management sold 4,148 Sanofi shares in Q3 2023, an estimated $224K.
  • Cozad Asset Management first reported a position in Sanofi in Q2 2018 and held it in 19 quarters.
  • Cozad Asset Management's Sanofi position peaked at $296K in Q2 2021.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Cozad Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.